"Rabeprazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Descriptor ID |
D064750
|
MeSH Number(s) |
D02.886.640.074.750 D03.383.725.024.750 D03.633.100.103.034.750
|
Concept/Terms |
Rabeprazole- Rabeprazole
- 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole
Rabeprazole Sodium- Rabeprazole Sodium
- Sodium, Rabeprazole
- 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, Sodium Salt
|
Below are MeSH descriptors whose meaning is more general than "Rabeprazole".
Below are MeSH descriptors whose meaning is more specific than "Rabeprazole".
This graph shows the total number of publications written about "Rabeprazole" by people in this website by year, and whether "Rabeprazole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rabeprazole" by people in Profiles.
-
El-Halabi MM, Zgheib N, Mansour NM, Malli A, Ghaith OA, Mahfouz R, Alam S, Sharara AI. CYP2C19 genetic polymorphism, rabeprazole and esomeprazole have no effect on the antiplatelet action of clopidogrel. J Cardiovasc Pharmacol. 2013 Jul; 62(1):41-9.
-
Mansour NM, Hashash JG, El-Halabi M, Ghaith O, Maasri K, Sukkarieh I, Malli A, Sharara AI. A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2011 Oct; 23(10):865-70.